# Oral Tyramine Pressor Response Study of CX157 Tablets in Healthy Male Volunteers

> **NCT01633437** · PHASE1 · COMPLETED · sponsor: **CeNeRx BioPharma Inc.** · enrollment: 12 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** CX157
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01633437
- **Lead sponsor:** CeNeRx BioPharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2012-07-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01633437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01633437, "Oral Tyramine Pressor Response Study of CX157 Tablets in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01633437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*